FDA Approves Eli Lilly Weight Loss Pill Foundayo for US
The FDA approved Eli Lilly's once-daily weight-loss pill Foundayo. The drug will cost $149 per month and is scheduled to begin shipping to patients on April 6.
Xurve View
Insights:
Xurve View
The United States Food and Drug Administration (FDA) has granted approval to the weight-loss pill developed by ELI LILLY & CO, marking a significant escalation in the pharmaceutical competition for obesity treatments. The medication, a once-daily oral treatment known as orforglipron, will be marketed under the brand name Foundayo.
